N-3 polyunsaturated fatty acids and HER2-positive breast cancer: Interest of the fat-1 transgenic mouse model over conventional dietary supplementation

Biochimie

Volumn 96, Issue 1, 2014, Pages 22-27

  Zou, Zuquan ^a,b,c   Bidu, Célia ^a,b   Bellenger, Sandrine ^a,b   Narce, Michel ^a,b   Bellenger, Jérôme ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Institut Médical de Génétique et d Immunologie   (France)

^c NINGBO UNIVERSITY   (China)

Author keywords

Fat 1 transgenic mouse model; HER2 positive breast cancer; n 3 fatty acids

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; FAT; FAT 1; OMEGA 3 FATTY ACID; PROTEIN KINASE B; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; LIPID PEROXIDATION; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

FAT-1 TRANSGENIC MOUSE MODEL; HER2-POSITIVE BREAST CANCER; N-3 FATTY ACIDS;

ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CAENORHABDITIS ELEGANS PROTEINS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACID DESATURASES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; RECEPTOR, ERBB-2;

EID: 84890568710     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.08.021     Document Type: Short Survey

References (67)

1. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle Estimates of the cancer incidence and mortality in Europe in 2006 Ann. Oncol. 18 3 2007 581 592
2. J. Mendelsohn, and J. Baselga Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J. Clin. Oncol. 21 2003 2787 2799
3. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: the complexity of targeted inhibitors Nat. Rev. Cancer 5 2005 341 354
4. M.A. Olayioye, R.M. Neve, H.A. Lane, and N.E. Hynes The ErbB signaling network: receptor heterodimerization in development and cancer EMBO J. 19 2000 3159 3167
5. M.X. Sliwkowski, G. Schaefer, R.W. Akita, J.A. Lofgren, V.D. Fitzpatrick, A. Nuijens, B.M. Fendly, R.A. Cerione, R.L. Vandlen, and K.L. Carraway 3rd Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin J. Biol. Chem. 269 1994 14661 14665
6. A. Gschwind, O.M. Fischer, and A. Ullrich The discovery of receptor tyrosine kinases: targets for cancer therapy Nat. Rev. Cancer 4 2004 361 370
7. G. Sithanandam, L.W. Fornwald, J. Fields, and L.M. Anderson Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549 Oncogene 24 2005 1847 1859
8. R. Pinkas-Kramarski, L. Soussan, H. Waterman, G. Levkowitz, I. Alroy, L. Klapper, S. Lavi, R. Seger, B.J. Ratzkin, M. Sela, and Y. Yarden Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions EMBO J. 15 1996 2452 2467
9. T. Holbro, R.R. Beerli, F. Maurer, M. Koziczak, C.F. Barbas 3rd, and N.E. Hynes The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation Proc. Natl. Acad. Sci. U. S. A. 100 2003 8933 8938
10. E. Tzahar, H. Waterman, X. Chen, G. Levkowitz, D. Karunagaran, S. Lavi, B.J. Ratzkin, and Y. Yarden A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor Mol. Cell. Biol. 16 1996 5276 5287
11. A.W. Burgess, H.S. Cho, C. Eigenbrot, K.M. Ferguson, T.P. Garrett, D.J. Leahy, M.A. Lemmon, M.X. Sliwkowski, C.W. Ward, and S. Yokoyama An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol. Cell. 12 2003 541 552
12. M.A. Owens, B.C. Horten, and M.M. Da Silva HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues Clin. Breast Cancer 5 2004 63 69
13. A. Citri, K.B. Skaria, and Y. Yarden The deaf and the dumb: the biology of ErbB-2 and ErbB-3 Exp. Cell. Res. 284 2003 54 65
14. L.E. Carlson, M. Angen, J. Cullum, E. Goodey, J. Koopmans, L. Lamont, J.H. MacRae, M. Martin, G. Pelletier, J. Robinson, J.S. Simpson, M. Speca, L. Tillotson, and B.D. Bultz High levels of untreated distress and fatigue in cancer patients Br. J. Cancer 2004 2297 2304
15. D. Yu, and M.C. Hung Role of erbB2 in breast cancer chemosensitivity Bioessays 22 2000 673 680
16. T. Sørlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, P.E. Lønning, and A.L. Børresen-Dale Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U. S. A. 98 2001 10869 10874
17. A. Travis, S.E. Pinder, J.F. Robertson, J.A. Bell, P. Wencyk, W.J. Gullick, R.I. Nicholson, D.N. Poller, R.W. Blamey, C.W. Elston, and I.O. Ellis C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators Br. J. Cancer 74 1996 229 233
18. B. Schoeberl, A.C. Faber, D. Li, M.C. Liang, K. Crosby, M. Onsum, O. Burenkova, E. Pace, Z. Walton, L. Nie, A. Fulgham, Y. Song, U.B. Nielsen, J.A. Engelman, and K.K. Wong An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation Cancer Res. 70 2010 2485 2494
19. L. Gianni, T. Pienkowski, Y.H. Im, L. Roman, L.M. Tseng, M.C. Liu, A. Lluch, E. Staroslawska, J. de la Haba-Rodriguez, S.A. Im, J.L. Pedrini, B. Poirier, P. Morandi, V. Semiglazov, V. Srimuninnimit, G. Bianchi, T. Szado, J. Ratnayake, G. Ross, and P. Valagussa Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Lancet Oncol. 13 2012 25 32
20. M.R. Campbell, D. Amin, and M.M. Moasser HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy Clin. Cancer Res. 16 2010 1373 1383
21. S.T. Lee-Hoeflich, L. Crocker, E. Yao, T. Pham, X. Munroe, K.P. Hoeflich, M.X. Sliwkowski, and H.M. Stern A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy Cancer Res. 68 2008 5878 5887
22. B. Gril, D. Palmieri, J.L. Bronder, J.M. Herring, E. Vega-Valle, L. Feigenbaum, D.J. Liewehr, S.M. Steinberg, M.J. Merino, S.D. Rubin, and P.S. Steeg Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain J. Natl. Cancer Inst. 100 2008 1092 1103
23. J.A. Drebin, V.C. Link, and M.I. Greene Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo Oncogene 2 1988 273 277
24. R.M. Hudziak, G.D. Lewis, M. Winget, B.M. Fendly, H.M. Shepard, and A. Ullrich p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor Mol. Cell. Biol. 9 1989 1165 1172
25. Y. Izumi, L. Xu, E. di Tomaso, D. Fukumura, and R.K. Jain Tumour biology: herceptin acts as an anti-angiogenic cocktail Nature 416 2002 279 280
26. X.F. Le, F.X. Claret, A. Lammayot, L. Tian, D. Deshpande, R. LaPushin, A.M. Tari, and R.C. Bast Jr. The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition J. Biol. Chem. 278 2003 23441 23450
27. K.E. Longva, N.M. Pedersen, C. Haslekås, E. Stang, and I.H. Madshus Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2 Int. J. Cancer 116 2005 359 367
28. M. Cuello, S.A. Ettenberg, A.S. Clark, M.M. Keane, R.H. Posner, M.M. Nau, P.A. Dennis, and S. Lipkowitz Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2 Cancer Res. 61 2001 4892 4900
29. K. Berns, H.M. Horlings, B.T. Hennessy, M. Madiredjo, E.M. Hijmans, K. Beelen, S.C. Linn, A.M. Gonzalez-Angulo, K. Stemke-Hale, M. Hauptmann, R.L. Beijersbergen, G.B. Mills, M.J. van de Vijver, and R. Bernards A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer Cancer Cell 12 2007 395 402
30. N.J. Nelson Migrant studies aid the search for factors linked to breast cancer risk J. Natl. Cancer Inst. 98 2006 436 438
31. P. Puska The north Karelia Project: 30 years success-fully preventing chronic diseases Diabetes Voice Spec. Issue 53 2008 26 29
32. K.K. Carroll, and L.M. Braden Dietary fat and mammary carcinogenesis Nutr. Cancer 6 1984 254 259
33. C.H. MacLean, S.J. Newberry, W.A. Mojica, P. Khanna, A.M. Issa, M.J. Suttorp, Y.W. Lim, S.B. Traina, L. Hilton, R. Garland, and S.C. Morton Effects of omega-3 fatty acids on cancer risk: a systematic review JAMA 295 2006 403 415
34. D. Engeset, E. Alsaker, E. Lund, A. Welch, K.T. Khaw, F. Clavel-Chapelon, A. Thiébaut, V. Chajès, T.J. Key, N.E. Allen, P. Amiano, M. Dorronsoro, A. Tjønneland, C. Stripp, P.H. Peeters, C.H. van Gils, M.D. Chirlaque, G. Nagel, J. Linseisen, M.C. Ocké, H.B. Bueno-de-Mesquita, C. Sacerdote, R. Tumino, E. Ardanaz, M.J. Sánchez, S. Panico, D. Palli, A. Trichopoulou, V. Kalapothaki, V. Benetou, J.R. Quirós, A. Agudo, K. Overvad, L. Bjerregaard, E. Wirfält, M. Schulz, H. Boeing, N. Slimani, and E. Riboli Fish consumption and breast cancer risk. The European prospective investigation into cancer and nutrition (EPIC) Int. J. Cancer 119 2006 175 182
35. H. Sun, Y. Hu, Z. Gu, R.T. Owens, Y.Q. Chen, and I.J. Edwards Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway Carcinogenesis 32 2011 1518 1524
36. D.P. Rose, J.M. Connolly, J. Rayburn, and M. Coleman Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice J. Natl. Cancer Inst. 87 1995 587 592
37. W.E. Hardman, C.P. Avula, G. Fernandes, and I.L. Cameron Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts Clin. Cancer Res. 7 2001 2041 2049
38. S.C. Larsson, M. Kumlin, M. Ingelman-Sundberg, and A. Wolk Dietary long chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms Am. J. Clin. Nutr. 79 2004 935 945
39. S.E. Olivo, and L. Hilakivi-Clarke Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis Carcinogenesis 26 2005 1563 1572
40. K.M. Nicholson, and N.G. Anderson The protein kinase B/Akt signalling pathway in human malignancy Cell Signal. 14 2002 381 395
41. J.S. Truan, J.M. Chen, and L.U. Thompson Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen Mol. Nutr. Food Res. 54 2010 1414 1421
42. J.A. Menendez, R. Lupu, and R. Colomer Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells Eur. J. Cancer Prev. 14 2005 263 270
43. L.D. Yee, D.C. Young, T.J. Rosol, A.M. Vanbuskirk, and S.K. Clinton Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone J. Nutr. 135 2005 983 988
44. M.B. MacLennan, S.E. Clarke, K. Perez, G.A. Wood, W.J. Muller, J.X. Kang, and D.W. Ma Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids J. Nutr. Biochem. 24 2013 388 395
45. J.A. Menendez, S. Ropero, R. Lupu, and R. Colomer Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells Ann. Oncol. 15 2004 1719 1721
46. P.D. Schley, D.N. Brindley, and C.J. Field (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells J. Nutr. 137 2007 548 553
47. P.D. Terry, T.E. Rohan, and A. Wolk Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence Am. J. Clin. Nutr. 77 2003 532 543
48. L.A. Cohen, J.Y. Chen-Backlund, D.W. Sepkovic, and S. Sugie Effect of varying proportions of dietary menhaden and corn oil on experimental rat mammary tumor promotion Lipids 28 1993 449 456
49. N. Wei, B. Wang, Q.Y. Zhang, M.T. Mi, J.D. Zhu, X.P. Yu, J.L. Yuan, K. Chen, J. Wang, and H. Chang Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats Nutr. Cancer 60 2008 810 825
50. G.J. Hopkins, T.G. Kennedy, and K.K. Carroll Polyunsaturated fatty acids as promoters of mammary carcinogenesis induced in Sprague-Dawley rats by 7,12-dimethylbenz[a]anthracene J. Natl. Cancer Inst. 66 1981 517 522
51. E. Lok, W.M. Ratnayake, F.W. Scott, R. Mongeau, S. Fernie, E.A. Nera, S. Malcolm, E. McMullen, P. Jee, and D.B. Clayson Effect of varying the type of fat in a semi-purified AIN-76A diet on cellular proliferation in the mammary gland and intestinal crypts in female Swiss Webster mice Carcinogenesis 13 1992 1735 1741
52. T. Sasaki, Y. Kobayashi, J. Shimizu, M. Wada, S. In'nami, Y. Kanke, and T. Takita Effects of dietary n-3-to-n-6 polyunsaturated fatty acid ratio on mammary carcinogenesis in rats Nutr. Cancer 30 1998 137 143
53. M.D. Holmes, D.J. Hunter, G.A. Colditz, M.J. Stampfer, S.E. Hankinson, F.E. Speizer, B. Rosner, and W.C. Willett Association of dietary intake of fat and fatty acids with risk of breast cancer JAMA 281 1999 914 920
54. M.C. Teale Omega 3 Fatty Acid Research 2008 Nova Science Publishers New York
55. K. Moriguchi, T. Yuri, K. Yoshizawa, K. Kiuchi, H. Takada, Y. Inoue, T. Hada, M. Matsumura, and A. Tsubura Dietary docosahexaenoic acid protects against N-methyl-N-nitrosourea-induced retinal degeneration in rats Exp. Eye Res. 77 2003 167 173
56. T. Yuri, N. Danbara, M. Tsujita-Kyutoku, K. Fukunaga, H. Takada, Y. Inoue, T. Hada, and A. Tsubura Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid Nutr. Cancer 45 2003 211 217
57. S. Manna, T. Chakraborty, S. Damodaran, K. Samanta, B. Rana, and M. Chatterjee Protective role of fish oil (Maxepa) on early events of rat mammary carcinogenesis by modulation of DNA-protein crosslinks, cell proliferation and p53 expression Cancer Cell. Int. 7 2007 6
58. M. Chatterjee, M. Janarthan, R. Manivannan, A. Rana, and M. Chatterjee Combinatorial effect of fish oil (Maxepa) and 1alpha,25-dihydroxyvitamin D(3) in the chemoprevention of DMBA-induced mammary carcinogenesis in rats Chem. Biol. Interact 188 2010 102 110
59. S. Hardy, Y. Langelier, and M. Prentki Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects Cancer Res. 60 2000 6353 6358
60. D.S. Knutzon, J.M. Thurmond, Y.S. Huang, S. Chaudhary, E.G. Bobik Jr., G.M. Chan, S.J. Kirchner, and P. Mukerji Identification of Delta5-desaturase from Mortierella alpina by heterologous expression in Bakers' yeast and canola J. Biol. Chem. 273 1998 29360 29366
61. J.X. Kang From fat to fat-1: a tale of omega-3 fatty acids J. Membr. Biol. 206 2005 165 172
62. S.H. Goodnight Jr., W.S. Harris, and W.E. Connor The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study Blood 58 1981 880 885
63. M.T. Clandinin, C.J. Field, K. Hargreaves, L. Morson, and E. Zsigmond Role of diet fat in subcellular structure and function Can. J. Physiol. Pharmacol. 63 1985 546 556
64. J.P. Spychalla, A.J. Kinney, and J. Browse Identification of an animal omega-3 fatty acid desaturase by heterologous expression in Arabidopsis Proc. Natl. Acad. Sci. U. S. A. 94 1997 1142 1147
65. Z.B. Kang, Y. Ge, Z. Chen, J. Cluette-Brown, M. Laposata, A. Leaf, and J.X. Kang Adenoviral gene transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells Proc. Natl. Acad. Sci. U. S. A. 98 2001 4050 4054
66. J.X. Kang, J. Wang, L. Wu, and Z.B. Kang Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids Nature 427 2004 504
67. J. Bellenger, S. Bellenger, A. Bataille, K.A. Massey, A. Nicolaou, M. Rialland, C. Tessier, J.X. Kang, and M. Narce High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition Diabetes 60 2011 1090 1099